Registry of Expensive Ovarian Cancer Treatment
start of the project: 12/2022
The Ovarian Registry is a multicenter, non-interventional, retrospective-prospective data collection project focusing on monitoring patients diagnosed with ovarian cancer.
Epithelial ovarian cancer (EOC) is the leading cause of death among women with gynecological malignancies. Due to the lack of specific symptoms and biological markers for early diagnosis, the majority of ovarian cancer cases are diagnosed at an advanced stage, with a 5-year survival rate of less than 50%. The registry will include patients over 18 years old who have a confirmed diagnosis of ovarian cancer, are undergoing targeted treatment, and have provided informed consent.
Project Objectives
The primary objective is to monitor the total number of ovarian cancer patients treated with expensive therapies in the Czech Republic.
The secondary objectives of the study are as follows:
Professional Guarantee
Project Management